ERYTECH Granted U.S. FDA Fast Track Designation for Eryaspase in Hypersensitive ALL

ERYTECH Granted U.S. FDA Fast Track Designation for Eryaspase in Hypersensitive ALL Fast Track designation for eryaspase underscores the need for new treatment options for patients who developed hypersensitivity reactions to pegylated asparaginas